1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Dermatitis Herpetiformis Market, By Treatment
5.1 Introduction
5.2 Therapeutics
5.2.1 Topical Corticosteroids
5.2.2 Sulfa Drugs
5.2.3 Dapsone
5.3 Dietary
5.3.1 Ready-to-eat Meals
5.3.2 Bakery Products
5.3.3 Pasta
5.4 Other Treatments
6 Global Dermatitis Herpetiformis Market, By Route of Administration
6.1 Introduction
6.2 Topical
6.3 Oral
7 Global Dermatitis Herpetiformis Market, By Distribution channel
7.1 Introduction
7.2 Retail stores
7.3 E-Commerce
7.4 Pharmacies
7.5 Other Distribution channels
8 Global Dermatitis Herpetiformis Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Allergan
10.2 3B scientific
10.3 Acros Organics
10.4 Aidance Scientific
10.5 AlliChem
10.6 Aidance Scientific
10.7 Canyon Bakehouse
10.8 GlaxoSmithKline Pharmaceuticals Ltd.
10.9 HBC Chem
10.10 Ivy Fine chemicals
10.11 Nostrum Laboratories Inc.
10.12 Pfizer Inc.
10.13 Shingles Skincare
10.14 AbbVie Inc.
10.15 Waterstone Technology
List of Tables
Table 1 Global Dermatitis Herpetiformis Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 3 Global Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 4 Global Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 5 Global Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 6 Global Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 7 Global Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 8 Global Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 9 Global Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 10 Global Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 11 Global Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 12 Global Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 13 Global Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 14 Global Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 15 Global Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 16 Global Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 17 Global Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 18 Global Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 19 Global Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
Table 20 North America Dermatitis Herpetiformis Market Outlook, By Country (2021-2030) ($MN)
Table 21 North America Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 22 North America Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 23 North America Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 24 North America Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 25 North America Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 26 North America Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 27 North America Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 28 North America Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 29 North America Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 30 North America Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 31 North America Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 32 North America Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 33 North America Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 34 North America Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 35 North America Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 36 North America Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 37 North America Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 38 North America Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
Table 39 Europe Dermatitis Herpetiformis Market Outlook, By Country (2021-2030) ($MN)
Table 40 Europe Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 41 Europe Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 42 Europe Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 43 Europe Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 44 Europe Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 45 Europe Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 46 Europe Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 47 Europe Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 48 Europe Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 49 Europe Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 50 Europe Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 51 Europe Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 52 Europe Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 53 Europe Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 54 Europe Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 55 Europe Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 56 Europe Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 57 Europe Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
Table 58 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Country (2021-2030) ($MN)
Table 59 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 60 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 61 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 62 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 63 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 64 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 65 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 66 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 67 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 68 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 69 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 70 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 71 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 72 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 73 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 74 Asia Pacific Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 75 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 76 Asia Pacific Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
Table 77 South America Dermatitis Herpetiformis Market Outlook, By Country (2021-2030) ($MN)
Table 78 South America Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 79 South America Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 80 South America Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 81 South America Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 82 South America Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 83 South America Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 84 South America Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 85 South America Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 86 South America Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 87 South America Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 88 South America Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 89 South America Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 90 South America Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 91 South America Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 92 South America Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 93 South America Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 94 South America Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 95 South America Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
Table 96 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Country (2021-2030) ($MN)
Table 97 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Treatment (2021-2030) ($MN)
Table 98 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 99 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Topical Corticosteroids (2021-2030) ($MN)
Table 100 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Sulfa Drugs (2021-2030) ($MN)
Table 101 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Dapsone (2021-2030) ($MN)
Table 102 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Dietary (2021-2030) ($MN)
Table 103 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Ready-to-eat Meals (2021-2030) ($MN)
Table 104 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Bakery Products (2021-2030) ($MN)
Table 105 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Pasta (2021-2030) ($MN)
Table 106 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 107 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 108 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Topical (2021-2030) ($MN)
Table 109 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Oral (2021-2030) ($MN)
Table 110 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Distribution channel (2021-2030) ($MN)
Table 111 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Retail stores (2021-2030) ($MN)
Table 112 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By E-Commerce (2021-2030) ($MN)
Table 113 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Pharmacies (2021-2030) ($MN)
Table 114 Middle East & Africa Dermatitis Herpetiformis Market Outlook, By Other Distribution channels (2021-2030) ($MN)
| ※参考情報 疱疹状皮膚炎は、主に皮膚に発生する自己免疫疾患の一つであり、粘膜や皮膚に小水疱が特徴的に見られる疾患です。この皮膚炎は、セリアック病と密接に関連しており、グルテンに対する過剰反応によって引き起こされることが多いです。疱疹状皮膚炎は、通常30代から40代の成人に多く見られますが、子供や若年層にも発症することがあります。 この疾患は、特に肘、膝、背中、臀部などに小さくてかゆみを伴う水疱を形成し、それが破れると湿疹のような病変になります。これらの水疱は非常にかゆいことが特徴であり、それが患者の日常生活に強い影響を与えることがあります。皮膚合併症や二次感染が起こる可能性もあるため、早期の診断と治療が重要です。 疱疹状皮膚炎には、主に二つのタイプがあります。一つは、典型的な疱疹状皮膚炎で、強いかゆみのある小水疱が皮膚に現れるものです。もう一つは、非典型的なタイプで、湿疹や皮膚の肥厚、色素沈着が見られることがあります。 この病気の治療には、グルテンを含む食品を避けることが最も重要です。患者は、食事療法を通じて、体内にグルテンが入らないようにすることで、症状の軽減が期待できます。さらに、抗炎症作用のある薬剤を使用することも有効です。特に、ジヒドロクロロチアジド（Dapsone）などの薬剤は有効とされていますが、使用にあたっては医師の指導が必要です。 関連技術としては、血清抗体検査が挙げられます。この検査では、患者の血液中にグルテンに対する抗体が存在するかどうかを調べることで、疱疹状皮膚炎やセリアック病の診断に役立ちます。また、皮膚の生検を行うことで、皮膚組織内の炎症や抗体の存在を確認することもあります。 疱疹状皮膚炎の関連疾患としては、セリアック病の他にも、甲状腺疾患や1型糖尿病などの自己免疫疾患が知られています。これらの疾患は、疱疹状皮膚炎患者においても併発することがあり、全身的な健康状態に注意を払う必要があります。 生活習慣としては、健康的な食事の維持や規則正しい生活が疱疹状皮膚炎の管理に役立ちます。ストレスが症状を悪化させることがあるため、リラクゼーションや適度な運動も重要です。また、適切なスキンケアを行い、皮膚を清潔に保つことで、二次感染を防ぐことができます。 疱疹状皮膚炎の診断や治療を受ける際は、専門の医療機関を受診することが推奨されます。専門医は、皮膚の状態や患者の医療歴を総合的に評価し、最適な治療法を提案します。治療を行うことで、生活の質を向上させ、長期的な健康維持に繋がることが期待されます。 このように疱疹状皮膚炎は、食事療法や適切な医療介入によって管理が可能です。患者は、自身の状態を理解し、必要に応じて専門家のサポートを求めることが重要です。これにより、日常生活における快適さを取り戻し、より良い生活を送ることができるでしょう。 |
